请使用支持JavaScript的浏览器!
主营:动物毒液多肽毒素
℡ 4000-520-616
℡ 4000-520-616
Smartox/Selective blocker of Nav1.4 channels /CON020-01000/1mg
产品编号:CON020-01000
市  场 价:¥6864.00
场      地:美国(厂家直采)
联系QQ:1570468124
电话号码:4000-520-616
邮      箱: info@ebiomall.com
美  元  价:$660.00
品      牌: Smartox
公      司:Smartox
公司分类:
Smartox/Selective blocker of Nav1.4 channels /CON020-01000/1mg
商品介绍

µ-conotoxin GIIIB is a 22 amino acid conopeptide originally isolated from the venom of the piscivorous marine snail Conus geographus. µ-conotoxin GIIIB adopts a compact structure consisting of a distorted 310-helix and a small ß-hairpin. µ-conotoxin GIIIB is stabilized by three disulphide bridges and is highly enriched in lysine and arginine residues, forming potential sites of interaction with Na channels. An unusual feature is the presence of three hydroxyproline residues. µ-conotoxin GIIIB is a useful probe to discriminate between neuronal and muscle sodium channels as it exhibits at least a 1000-fold specificity for muscle versus nerve sodium channels. µ-Conotoxin GIIIB selectively blocks Nav1.4 voltage-dependent sodium channels, which are predominantly expressed in muscle, with an affinity close to 20 nM. µ-Conotoxin GIIIB appears to physically occlude the channel pore by binding on site I of the Na+ channel.


Description:

Product code: N/A. Category: Sodium channels. Tag: Nav1.4.

AA sequence: Arg-Asp-Cys3-Cys4-Thr-Hyp-Hyp-Arg-Lys-Cys10-Lys-Asp-Arg-Arg-Cys15-Lys-Hyp-Met-Lys-Cys20-Cys21-Ala-NH2
Disulfide bonds: Cys3-Cys15, Cys4-Cys20 and Cys10-Cys21
Length (aa): 22
Formula: C101H175N39O30S7
Molecular Weight: 2640.26 Da
Appearance: White lyophilized solid
Solubility: water and saline buffer
CAS number:
Source: Synthetic
Purity rate: > 97 %

Reference:

Molecular Basis of Isoform-specific μ-Conotoxin Block of Cardiac, Skeletal Muscle, and Brain Na+ Channels

mu-Conotoxins (mu-CTXs) block skeletal muscle Na(+) channels with an affinity 1-2 orders of magnitude higher than cardiac and brain Na(+) channels. Although a number of conserved pore residues are recognized as critical determinants of mu-CTX block, the molecular basis of isoform-specific toxin sensitivity remains unresolved. Sequence comparison of the domain II (DII) S5-S6 loops of rat skeletal muscle (mu1, Na(v)1.4), human heart (hh1, Na(v)1.5), and rat brain (rb1, Na(v)1.1) Na(+) channels reveals substantial divergence in their N-terminal S5-P linkers even though the P-S6 and C-terminal P segments are almost identical. We used Na(v)1.4 as the backbone and systematically converted these DII S5-P isoform variants to the corresponding residues in Na(v)1.1 and Na(v)1.5. The Na(v)1.4–>Na(v)1.5 variant substitutions V724R, C725S, A728S, D730S, and C731S (Na(v)1.4 numbering) reduced block of Na(v)1.4 by 4-, 86-, 12-, 185-, and 55-fold respectively, rendering the skeletal muscle isoform more “cardiac-like.” Conversely, an Na(v)1.5–> Na(v)1.4 chimeric construct in which the Na(v)1.4 DII S5-P linker replaces the analogous segment in Na(v)1.5 showed enhanced mu-CTX block. However, these variant determinants are conserved between Na(v)1.1 and Na(v)1.4 and thus cannot explain their different sensitivities to mu-CTX. Comparison of their sequences reveals two variants at Na(v)1.4 positions 729 and 732: Ser and Asn in Na(v)1.4 compared with Thr and Lys in Na(v)1.1, respectively. The double mutation S729T/N732K rendered Na(v)1.4 more “brain-like” (30-fold downward arrow in block), and the converse mutation T925S/K928N in Na(v)1.1 reproduced the high affinity blocking phenotype of Na(v)1.4. We conclude that the DII S5-P linker, although lying outside the conventional ion-conducting pore, plays a prominent role in mu-CTX binding, thus shaping isoform-specific toxin sensitivity.

Ronald A. Li, et al. (2003) Molecular Basis of Isoform-specific μ-Conotoxin Block of Cardiac, Skeletal Muscle, and Brain Na+ Channels. JBC. PMID: 12471026

Conus geographus toxins that discriminate between neuronal and muscle sodium channels

We describe the properties of a family of 22-amino acid peptides, the mu-conotoxins, which are useful probes for investigating voltage-dependent sodium channels of excitable tissues. The mu-conotoxins are present in the venom of the piscivorous marine snail, Conus geographus L. We have purified seven homologs of the mu-conotoxin set and determined their amino acid sequences, as follows, where Hyp = trans-4-hydroxyproline. GIIIA R.D.C.C.T.Hyp.Hyp.K.K.C.K.D.R.Q.C.K.Hyp.Q.R.C.C.A-NH2 [Pro6]GIIIA R.D.C.C. T.P.Hyp.K.K.C.K.D.R.Q.C.K.Hyp.Q.R.C.C.A-NH2 [Pro7]GIIIA R.D.C.C.T.Hyp.P.K.K.C.K.D.R.Q.C.R.Hyp.Q.R.C.C.A-NH2 GIIIB R.D.C.C.T.Hyp.Hyp.R.K.C.K.D.R.R.C.K.Hyp.M.K.C.C.A-NH2 [Pro6]GIIIB R.D.C.C.T.P.Hyp.R.K.C.K.D.R.R. C.K.Hyp.M.K.C.C.A-NH2 [Pro7]GIIIB R.D.C.C.T.Hyp.P.R.K.C.K.D.R.R.C.K.Hyp.M.K.C.C.A-NH2 GIIIC R.D.C.C.T.Hyp.Hyp.K.K.C.K.D.R.R.C.K.Hyp.L.K.C.C.A-NH2. Using the major peptide (GIIIA) in electrophysiological studies on nerve-muscle preparations and in single channel studies using planar lipid bilayers, we have established that the toxin blocks muscle sodium channels, while having no discernible effect on nerve or brain sodium channels. In bilayers the blocking kinetics of GIIIA were derived by statistical analysis of discrete transitions between blocked and unblocked states of batrachotoxin-activated sodium channels from rat muscle. The kinetics conform to a single-site, reversible binding equilibrium with a voltage-dependent binding constant. The measured value of the equilibrium KD for GIIIA is 100 nM at OmV, decreasing e-fold/34 mV of hyperpolarization. This voltage dependence of blocking is similar to that of tetrodotoxin and saxitoxin as measured by the same technique. The tissue specificity and kinetic characteristics suggest that the mu-conotoxins may serve as useful ligands to distinguish sodium channel subtypes in different tissues.

Cruz LJ, et al. (1985) Conus geographus toxins that discriminate between neuronal and muscle sodium channels. JBC. PMID: 2410412

Novel Structural Determinants of m-Conotoxin (GIIIB) Block in Rat Skeletal Muscle (m1) Na+ Channels

mu-Conotoxin (mu-CTX) specifically occludes the pore of voltage-dependent Na(+) channels. In the rat skeletal muscle Na(+) channel (mu1), we examined the contribution of charged residues between the P loops and S6 in all four domains to mu-CTX block. Conversion of the negatively charged domain II (DII) residues Asp-762 and Glu-765 to cysteine increased the IC(50) for mu-CTX block by approximately 100-fold (wild-type = 22.3 +/- 7.0 nm; D762C = 2558 +/- 250 nm; E765C = 2020 +/- 379 nm). Restoration or reversal of charge by external modification of the cysteine-substituted channels with methanethiosulfonate reagents (methanethiosulfonate ethylsulfonate (MTSES) and methanethiosulfonate ethylammonium (MTSEA)) did not affect mu-CTX block (D762C: IC(50, MTSEA+) = 2165.1 +/- 250 nm; IC(50, MTSES-) = 2753.5 +/- 456.9 nm; E765C: IC(50, MTSEA+) = 2200.1 +/- 550.3 nm; IC(50, MTSES-) = 3248.1 +/- 2011.9 nm) compared with their unmodified counterparts. In contrast, the charge-conserving mutations D762E (IC(50) = 21.9 +/- 4.3 nm) and E765D (IC(50) = 22.0 +/- 7.0 nm) preserved wild-type blocking behavior, whereas the charge reversal mutants D762K (IC(50) = 4139.9 +/- 687.9 nm) and E765K (IC(50) = 4202.7 +/- 1088.0 nm) destabilized mu-CTX block even further, suggesting a prominent electrostatic component of the interactions between these DII residues and mu-CTX. Kinetic analysis of mu-CTX block reveals that the changes in toxin sensitivity are largely due to accelerated toxin dissociation (k(off)) rates with little changes in association (k(on)) rates. We conclude that the acidic residues at positions 762 and 765 are key determinants of mu-CTX block, primarily by virtue of their negative charge. The inability of the bulky MTSES or MTSEA side chain to modify mu-CTX sensitivity places steric constraints on the sites of toxin interaction.

Ronald A. Li, et al. (2000) Novel Structural Determinants of m-Conotoxin (GIIIB) Block in Rat Skeletal Muscle (m1) Na+ Channels. JBC.PMID: 10859326

Hyperpolarized shifts in the voltage dependence of fast inactivation of Nav1.4 and Nav1.5 in a rat model of critical illness myopathy

Critical illness myopathy is a disorder in which skeletal muscle becomes electrically inexcitable. We previously demonstrated that a shift in the voltage dependence of fast inactivation of sodium currents contributes to inexcitability of affected fibres in an animal model of critical illness myopathy in which denervated rat skeletal muscle is treated with corticosteroids (steroid-denervated; SD). In the current study we examined whether expression of Nav1.5 contributes to the altered voltage dependence of sodium channel inactivation in SD muscle. We used TTX and mu-conotoxin GIIIB to selectively block Nav1.4 in SD muscle and found that the level of Nav1.5 did not correlate closely with the shift in fast inactivation. Surprisingly, we found that the voltage dependence of inactivation of Nav1.4 was similar to that of Nav1.5 in skeletal muscle in vivo. In severely affected fibres, inactivation of both Nav1.4 and Nav1.5 was shifted towards hyperpolarized potentials. We examined the role of denervation and steroid treatment in the shift of the voltage dependence of inactivation and found that both denervation and steroid treatment contribute to the shift in inactivation. Our results suggest that modulation of the voltage dependence of inactivation of both Nav1.4 and Nav1.5 in vivo contributes to loss of electrical excitability in SD muscle.

Gregory N. Filatov and Mark M. Rich (2004) Hyperpolarized shifts in the voltage dependence of fast inactivation of Nav1.4 and Nav1.5 in a rat model of critical illness myopathy. J. Physiol. PMID: 15254148

品牌介绍

Smartox Biotechnolgy的多肽毒素产品如下:

 

1. 作用于钠离子通道(Sodium channel)的毒素

 

Toxin name

Catalog #

Target

Phrixotoxin-3

13PHX003

Selective blocker of Nav1.2

µ-conotoxin GIIIB

CON020

Selective blocker of Nav1.4

µ-conotoxin CnIIIC

CON021

Selective blocker of Nav1.4

μ-conotoxin PIIIA

08CON006

Selective blocker of Nav1.4

Jingzhaotoxin-III

12JZH003

Selective blocker of Nav1.5

ProTx-II

07PTX002

Selective blocker of Nav1.7

ProTx-II Biotin

12PTB002

Selective blocker of Nav1.7

ProTx-I

12PTX001

Blocker of Nav1.8, Nav1.2, Nav1.5, Nav1.7

Huwentoxin-I

07HWT001

Blocker of TTX-S

Huwentoxin-IV

08HWT002

Blocker of TTX-S

Hainantoxin-III

13HTX003

Blocker of TTX-S

Hainantoxin-IV

12HTX001

Blocker of TTX-S

GsAF-I

12GSF001

Blocker of TTX-S

GsAF-II

12GSF002

Blocker of TTX-S

 

2. 作用于钾离子通道(Potassium channel)的毒素

 

Toxin name

Catalog #

Target

KCa channels

Apamin 蜜蜂神经毒素

08APA001

SK1, SK2, SK3

Charybdotoxin 蝎毒素

11CHA001

KCa1.1, KCa3.1 - Kv1.2, Kv1.3, Kv1.6

Iberiotoxin

12IBX001

KCa1.1

Leiurotoxin 1 (Scyllatoxin)

10LEI001

SK1, SK2, SK3

Tamapin

10TAM001

SK1, SK2, SK3

Kaliotoxin-1

08KTX002

BK, Kv1.1, Kv1.2, Kv1.3

Kv channels

ShK

08SHK001

Kv1.3, Kv1.1, Kv1.4, Kv1.6

TMR-ShK

SAT001

Kv1.3, Kv1.1

Margatoxin

08MAG001

Kv1.3

(Dap22)-ShK

13SHD001

Kv1.3

ADWX-1

13ADW001

Kv1.3

HsTx1

08NEU001

Kv1.3, Kv1.2

Agitoxin-2

13AGI002

Kv1.3, Kv1.1

Maurotoxin

08MAR001

Kv1.2, KCa3.1

Guangxitoxin 1E

11GUA002

Kv2.1, Kv2.2

Stromatoxin 1 NEW

SCT01

Kv2.1, Kv2.2

Kaliotoxin-1

08KTX002

BK, Kv1.1, Kv1.2, Kv1.3

Charybdotoxin

11CHA001

KCa1.1, KCa3.1 - Kv1.2, Kv1.3, Kv1.6

Phrixotoxin-2

PHX002

Kv4.2, Kv4.3

AmmTx3 NEW

AMX001

A-type potassium channels

Inwardly rectifying potassium channels

TertiapinQ

08TER001

Kir1.1, Kir3.1/3.4, Kir3.1/3.2-KCa1.1

hERG/Kv11.1

BeKm-1

13BEK001

ERG1

 

3. 作用于钙离子通道(Calcium channel)的毒素

 

Toxin name

Catalog #

Target

High voltage-gated Ca2+ channels

ω-agatoxin IVA

11AGA001

P/Qtype

ω-Conotoxin MVIIC

08CON002

P/Qtype, N-type

ω-Conotoxin MVIIA

08CON001

N-type

ω-Conotoxin GVIA

08CON003

N-type

ω-Conotoxin SO3

08CON013

N-type

Huwentoxin I

07HWT001

N-type

ProTx-II

07PTX002

T-type, L-type

Intermediate voltage-gated Ca2+ channels

SNX482

08SNX002

R-type

Low voltage-gated Ca2+ channels

ProTx-I

12PTX001

T-type

ProTx-II

07PTX002

T-type, L-type

Ryanodine receptors

Maurocalcine

07PAU001

Ryr1

 

4. 作用于氯离子通道(Chloride channel)的毒素

 

Toxin name

Catalog #

Target

Chlorotoxin

08CHL001

Blocker of small conductance Cl- channels

GaTx1

13GTX001

Selective blocker of CFTR channel

GaTx2

10GTX002

Selective blocker of ClC-2 channel

 

5. 作用于乙酰胆碱受体(Acetylcholine receptor)的毒素

 

Toxin name

Catalog #

Target

α-conotoxin PeIA

13CON017

α9α10, α3β2 subunits

α-Conotoxin PrXA

13CON016

α1/β1/ε/δ, α1/β1/γ/δ subunits

Waglerin-1

12WAG001

MusclenAChR

α-conotoxin MI

08CON012

α1/δsubunits

α-conotoxin GI

08CON005

α/δsite

α-conotoxin IMI

08CON011

α7 homomeric nAChR

α-conotoxin GID

CON019

Blocker of α3β2, α7 and α4β2 nAChRs

 

6. 含N-甲基-D-天冬氨酸NR2B

(NMDA, NR2B containing N-methyl-D-aspartate)

Conantokin-G

选择性、特异性抑制含NR2B的NMDAR。Conantokin-G能剂量依赖性抑制Ca2+内流,抑制NMDA诱导的兴奋性中毒效应。研究表明,在小鼠皮层神经元,Conantokin-G阻滞NMDA引发的电流信号的IC50值为480 nM。

 

7. 作用于酸敏感离子通道(ASIC channel, Acid-Sensing Ion Channel)的毒素

 

Toxin name

Catalog #

Target

APETx2

07APE002

Selective blocker of ASIC3

Psalmotoxin1/PcTx1

13PCT001

Selective blocker of ASIC1a

Ugr9-1

13UGR001

Blocker of ASIC3

 

8. 作用于瞬时受体电位(TRP channel, transient receptor potential)的毒素

 

Toxin name

Catalog #

Target

GsMTx4

08GSM001

TRPC, TRPA

Vanillotoxin3

10VAN003

Activator of TRPV1

ProTx-I

12PTX001

Antagonist of TRPA1

 

9. 作用于嘌呤能通道(Purinergic channel)的毒素

Purotoxin-1

选择性抑制P2X3受体。100 nM Purotoxin-1 (PT-1)选择性抑制P2X3受体通道,在大鼠DRG神经元上,使用膜片钳实验表明:PT-1对电压门控通道和TRPV1均无抑制效应。10 µM ATP和100 µM α,β Methylene-ATP浓度下Purotoxin-1对P2X3受体有选择性作用,在该ATP浓度下Purotoxin-1对P2X2和杂化二聚体P2X2/3并无激动作用。Purotoxin-1对疼痛的潜在治疗作用。

 

10. 作用于其它膜受体通道(Others)的毒素

Smartox Biotechnology还提供其他类型的膜受体抑制剂:

 

Toxin name

Catalog #

Target

Morphiceptin

011CAS001

Agonist of µ-opoid receptors

Lys-conopressin G

11CON14

Vasopressin-like peptide

GsMTx4

08GSM001

Mechano sensitive ion channels

Obtustatin

10OBT001

Blocks the binding of α1β1  integrin to collagen IV

Rho-Conotoxin TIA

CON022

Blocks α1-adrenergic receptor

 

 

公司简介

Smartox Biotechnology是全球唯一一家专门生产动物毒液多肽毒素,用于细胞离子通道功能研究的生物医药公司。多肽毒素在生物制药领域具有重要的使用价值。

Smartox Biotechnology于2009年由来自Grenoble神经科学研究所(Grenoble Institute of Neuroscience)的Michel De Waard博士创立。Smartox Biotechnology专门研究动物毒液,制作合成多种毒液中的多肽成分(常称为毒素)。De Waard博士研究离子通道与毒素多肽的关系,尤其是鉴定、开发毒素多肽作为治疗性分子或细胞穿透肽(cell penetrating peptides, CPP)。其研究团队在毒液分离,药理性活性肽鉴定、富半胱氨酸肽定性、制作和优化等方面具有独特、丰富的经验。2010年,Smartox Biotechnolgy被法国研究部(Ministry of Research)授予“新兴企业OSEO奖(OSEO prize for emerging businesses)”。

总之,Smartox Biotechnolgy提供一系列高质量、具开创价值的多肽毒素。这些化合物在离子通道 研究中具有高的亲和性和选择性,是相应领域科学研究理想的生物毒素提供商和贴心的合作伙伴。


自营商城图标
厂家直采
全球直采 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔